1. Home
  2. GRMN vs IQV Comparison

GRMN vs IQV Comparison

Compare GRMN & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Garmin Ltd. (Switzerland)

GRMN

Garmin Ltd. (Switzerland)

HOLD

Current Price

$279.69

Market Cap

49.4B

Sector

Industrials

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$269.93

Market Cap

43.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRMN
IQV
Founded
1990
1982
Country
Switzerland
United States
Employees
N/A
93000
Industry
Industrial Machinery/Components
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.4B
43.1B
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
GRMN
IQV
Price
$279.69
$269.93
Analyst Decision
Buy
Strong Buy
Analyst Count
6
16
Target Price
$256.40
$227.13
AVG Volume (30 Days)
612.1K
1.2M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
1.66%
N/A
EPS Growth
17.67
4.67
EPS
2.09
1.61
Revenue
$7,245,519,000.00
$9,739,000,000.00
Revenue This Year
$12.15
$6.77
Revenue Next Year
$8.69
$5.89
P/E Ratio
$135.24
$162.59
Revenue Growth
15.06
41.60
52 Week Low
$186.67
$154.50
52 Week High
$314.28
$271.80

Technical Indicators

Market Signals
Indicator
GRMN
IQV
Relative Strength Index (RSI) 51.21 65.29
Support Level $228.04 $159.91
Resistance Level $314.28 $271.80
Average True Range (ATR) 5.62 6.15
MACD -1.58 -1.48
Stochastic Oscillator 56.75 69.82

Price Performance

Historical Comparison
GRMN
IQV

About GRMN Garmin Ltd. (Switzerland)

Garmin produces GPS-enabled hardware and software for five sectors: fitness, outdoors, automotive, aviation, and marine. Garmin has built a strong reputation for durable, high-precision devices through a vertically integrated design and manufacturing approach. The company's product lines include smartwatches, fitness trackers, communication equipment, and a comprehensive suite of systems for marine and aviation navigation. Garmin operates globally, with its business focused primarily on North America and Europe.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: